Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review-Reference-Cited by-同舟云学术

Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review

Published:2018-11-09 Issue:1 Volume:19 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Yang Jing,Luo Jian,Yang Ling,Yang Dan,Wang Dan,Liu Bicui,Huang Tingxuan,Wang Xiaohu,Liang Binmiao,Liu Chuntao^ORCID

Funder

the National Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s12931-018-0912-y.pdf

Reference43 articles.

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78.

2. Global Strategy for Asthma Management and Prevention, 2017. Available from: http://www.ginasthma/.org .

3. Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise asthma and LInk to symptoms and experience (REALISE) survey. Npj Primary Care Respiratory Medicine. 2014;24.

4. Stead RJ, Cooke NJ. Adverse effects of inhaled corticosteroids. Bmj. 1989;298:403–4.

5. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med. 2001;193:255–61.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast Cells in Aspirin-Exacerbated Respiratory Disease;Current Allergy and Asthma Reports;2024-01-13

2. Over-expression of CRTH2 indicates eosinophilic inflammation and poor prognosis in recurrent nasal polyps;Frontiers in Immunology;2022-11-18

3. Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma;Chest;2022-08

4. Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19;Allergy;2022-02-25

5. An introduction to eosinophils and their biology;Eosinophilic Lung Diseases;2022-01